Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

This company has been marked as potentially delisted and may not be actively trading.

Evoke Pharma (EVOK) Earnings Date, Estimates & Call Transcripts

Evoke Pharma logo

Evoke Pharma Earnings Summary

Evoke Pharma announced Q3 2025 earnings on November 13, 2025, reporting an EPS of -$0.45, which hit the consensus estimate of -$0.45. Quarterly revenue was reported to be $4.28 million, below analysts' expectations of $4.33 million. Evoke Pharma currently has a trailing EPS of -$2.07

Latest Q3
Earnings Date
Nov. 13Estimated
Consensus EPS
(Nov. 13)
-$0.45
Actual EPS
(Nov. 13)
-$0.45
Actual Revenue
(Nov. 13)
$4.28M

Q3 2025 Earnings Resources

Get Evoke Pharma Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Evoke Pharma and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

EVOK Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

EVOK Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Evoke Pharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/13/2025Q3 2025-$0.45-$0.45--$0.45$4.33M$4.28M
8/14/2025Q2 2025-$0.30-$0.62 -$0.32-$0.62$3.80M$3.75M
5/12/2025Q1 2025-$0.33-$0.51 -$0.18-$0.51$3.32M$3.08M
3/13/2025Q4 2024-$0.25-$0.49 -$0.24-$0.49$3.08M$3.31M
11/7/2024---$0.94--$0.94-$2.65M
8/13/2024--$0.72-$0.93 -$0.21-$0.93-$2.55M

Data powered by Fiscal.ai.


This page (NASDAQ:EVOK) was last updated on 5/21/2026 by MarketBeat.com Staff.
From Our Partners